Pharma Summit 2025

Mateo de Bardeci

Co-founder of DeepPsy AG

Mateo de Bardeci is the co-founder of DeepPsy AG, a company dedicated to precision psychiatry through EEG and ECG analysis. He holds an MSc ETH in Biomedical Engineering (focus on Data Science & Neuroinformatics) and a BSc in Physics from ETH Zurich. His research collaborations include the Electrophysiology and Prediction in Psychiatry (EPP) group at UZH and Arzneimittelsicherheit in der Psychiatrie (AMSP). With multiple first- and co-authored publications, Mateo combines academic expertise with entrepreneurial vision to develop innovative approaches for psychiatric treatment stratification, advancing data-driven psychiatry through translational medicine.